Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00222508 · ClinicalTrials.gov registry record
The Microvascular Complications Study
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 150
- Enrollment target
NCT00222508: Completed study, sponsored by University of Minnesota.
NCT00222508 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00222508 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
Our general aim is to determine the prevalence of diabetic microvascular complications in CFRD patients with and without fasting hyperglycemia, and to explore whether the presence of these complications is related to diabetes or CF factors. This cross-sectional study will provide pilot data for a longitudinal study of diabetes complications in CF.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2001-04 |
| Est. Completion | 2005-07 |
What the finished NCT00222508 record still lists
NCT00222508 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00222508 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00222508 about?
NCT00222508 is a clinical study titled "The Microvascular Complications Study". Our general aim is to determine the prevalence of diabetic microvascular complications in CFRD patients with and without fasting hyperglycemia, and to explore whether the presence of these complications is related to diabetes or CF factors. This cross-sectional study will provide pilot data for a lo...
What is the current status of trial NCT00222508?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2001-04. Estimated completion is 2005-07.
Who is sponsoring clinical trial NCT00222508?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia